Articles
Page 14 of 19
-
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P318
-
HPV infection in HIV-positive subjects and molecular epidemiology
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P294 -
Factors associated with anxiety, depression and cognitive impairment in elderly patients receiving HAART
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P292 -
Rituximab and Castleman disease and Kaposi's sarcoma
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P290 -
Thrombopenia and/or splenomegaly in HIV/HCV co-infected patients with mild liver fibrosis alerts for the risk of portal hepatopathy
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P286 -
Impact of highly active antiretroviral therapy on cytomegalovirus viraemia, in the absence of specific anti-cytomegalovirus therapy
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P255 -
Early predictors of outcome and management of PCP in Glasgow: 11 years experience in the post-antiretroviral era
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P253 -
Once-daily darunavir (DRV) used in routine clinical care produces trough DRV drug concentrations in excess of 30× the protein-corrected (PC) EC50for wild-type HIV
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P249 -
The effect of food on ritonavir bioavailability following administration of ritonavir 100 mg film-coated tablet in healthy adult subjects
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P247 -
Efficacy and safety of Truvada®in HIV-1 pregnant women: report of 23 cases
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P222 -
Abstract withdrawn
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P220 -
Prevention of mother-to-child transmission of HIV in the HAART era: patterns in use of neonatal prophylaxis
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P218 -
Progression to AIDS in HIV vertically infected children diagnosed and ARV treated from first year of life
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P216 -
Tenofovir toxicity in children: two clinical cases
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P214 -
Activation of HIV-specific CD8+ T lymphocytes by histamine depends also on the total NK cells
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P212 -
Genotypic susceptibility to tipranavir of HIV-1 isolates in treatment-experienced patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P190 -
Correlation between patterns of HIV-1 drug resistance and drug administration in antiretroviral experienced patients in Greece during 1999–2006
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P186 -
Continuous decline in prevalence of drug resistance mutations among naïve and cART experienced HIV-positive patients in Poland over time
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P184 -
HIV lamivudine resistance mutations in HBV co-infected Romanian patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P182 -
Re-evaluation of resistance algorithms for lopinavir/ritonavir in the TITAN trial
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P178 -
Adherence, coping strategies and depression in highly antiretroviral-experienced patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P176 -
A cross-sectional comparison of serum bone markers in patients on stable abacavir (ABC) or tenofovir (TDF) containing therapy
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P151 -
Uridine supplementation with Mitocnol attenuates mitochondrial cardiomyopathy induced by zidovudine and zalcitabine
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P147 -
Highly active antiretroviral treatment (HAART) interruption leads to an increase in mitochondrial DNA content in HIV-infected children
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P143 -
Long-term satisfaction and benefits on quality of life in HIV-infected people after reparatory treatment with Aquamid®for facial Lipoatrophy
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P114 -
Factors related to low HDL-cholesterol in HIV-infected patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P112 -
Effect of antiretroviral therapy on homocysteine plasma concentrations in patients with AIDS
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P108 -
Peri-renal fat diameter is related to intima media thickness and renal arterial resistance index in HIV-1 infected patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P106 -
Sticky platelet syndrome (SPS) in patients with AIDS: a cross-sectional study
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P104 -
Comparative assessment of coronary risk in HIV-infected patient cohort using Framingham index and Spanish validated coronary risk index: REGICOR
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P93 -
Protease inhibitor-induced cardiotoxicity: direct effects on cell viability and intracellular calcium levels
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P91 -
Protease inhibitor atazanavir induces leukocyte-endothelial cell interactions in the microvasculature
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P89 -
Management of antiretroviral therapy (ART) in Albania
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P87 -
Rarity of mixed cryoglobulinemia (MC) in HIV-1 (+) treatment-naïve patients (09/2006–5/07/2008) and long-term follow-up
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P85 -
Changes in hematological parameters after switching treatment of HIV-infected patients from zidovudine to abacavir or tenofovir DF
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P60 -
Switching to nevirapine-based HAART in virologically-suppressed patients: influence of a longer twice-daily induction period on once-a-day dosing
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P56 -
Switch from enfuvirtide (ENF) to raltegravir (RAL): a simplification option for heavily pretreated HIV patients (pts)
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P52 -
Transient therapy with quadruple NRTI provides immune stability in patients with multidrug resistant HIV-1 and no options for suppressive regimens
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P50 -
Darunavir in patients who failed on fos-amprenavir: efficacy at week 48
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P48 -
O424 Resistance development in virological failures with DRV/r or LPV/r: 96-week analysis of the Phase III TITAN trial in treatment-experienced patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O46 -
Efficacy and tolerance of combination of maraviroc with MK-0518, boosted TMC-114, TMC-125, in heavily pre-treated CCR5-positive patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P46 -
O422 Do the disadvantages of late initiation of HAART persist in patients achieving and maintaining viral load (VL) suppression for a year on HAART?
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O44 -
O411 HIV-TB co-infection and TB drug resistance: an emerging threat to HIV and TB programmes
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O38 -
POWER 1 and 2: combined final 144-week efficacy and safety results for darunavir/ritonavir (DRV/r) 600/100 mg BID in treatment-experienced HIV patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P21 -
HAART in HIV+ naive elderly patients: immuno-virological response and clinical outcome
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P17 -
The TOKEN study: safety and efficacy of Truvada or Kivexa in combination with efavirenz in treatment-naïve predominantly black African HIV patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P15 -
O135 Seek and treat for optimal prevention of HIV/AIDS (STOP HIV/AIDS)
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O13 -
The Rainbow Cohort: saquinavir/r is effective and well tolerated in antiretroviral therapy (ART)-naïve patients – 48-week results from Germany
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P13 -
O132 Secondline ART in the developing world
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O11 -
Pathogenesis of HIV infection: implications for treatment and prevention
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):K1